Evidence map›Paper›PMID 26483519›Full record

ArticleJournal of bacteriology2016

Protein Analysis of Sapienic Acid-Treated Porphyromonas gingivalis Suggests Differential Regulation of Multiple Metabolic Pathways.

Carol L Fischer, Deborah V Dawson, Derek R Blanchette, David R Drake, Philip W Wertz, Kim A Brogden

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Bile acid fitness determinants of abioRxiv : the preprint server for biology · 2023
    Article
  3. Article
  4. Antimicrobial Activity of Host-Derived Lipids.Antibiotics (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Carol L FischerDows Institute for Dental Research, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA carol-bratt@uiowa.edu.
Deborah V DawsonDows Institute for Dental Research, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA Department of Pediatric Dentistry, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA.
Derek R BlanchetteDows Institute for Dental Research, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA.
David R DrakeDows Institute for Dental Research, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA Department of Endodontics, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA.
Philip W WertzDows Institute for Dental Research, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA Department of Oral Pathology, Radiology, and Medicine, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA.
Kim A BrogdenDows Institute for Dental Research, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA Department of Periodontics, College of Dentistry, The University of Iowa, Iowa City, Iowa, USA.
University of Iowa · US

Funding

University of Iowa Institutional Training Program in Oral Health ResearchT90DE023520 · NIDCR · UNIVERSITY OF IOWA · PI STEVEN M. LEVY · 2013 to 2026
$5.6M
Institutional Training Program in Oral Health ResearchT32DE014678 · NIDCR · UNIVERSITY OF IOWA · PI SQUIER, CHRISTOPHER · 2002 to 2011
$5.2M
Defensin-induced Adaptive Immunity to HagBR01DE014390 · NIDCR · UNIVERSITY OF IOWA · PI BROGDEN, KIM A · 2003 to 2014
$3.4M
University of Iowa Institutional Training Program in Oral Health ResearchR90DE024296 · NIDCR · UNIVERSITY OF IOWA · PI STEVEN M. LEVY · 2013 to 2026
$1.8M
Antimicrobial Lipids within the Oral CavityR01DE018032 · NIDCR · UNIVERSITY OF IOWA · PI WERTZ, PHILIP WESLEY · 2008 to 2010
$785k
NIDCR NIH HHS R01 DE014390NIDCR NIH HHS R01 DE018032NIDCR NIH HHS R90 DE024296NIDCR NIH HHS T32 DE014678NIDCR NIH HHS T90 DE023520
6 · The paper itself

Abstract

unlabelledLipids endogenous to skin and mucosal surfaces exhibit potent antimicrobial activity against Porphyromonas gingivalis, an important colonizer of the oral cavity implicated in periodontitis. Our previous work demonstrated the antimicrobial activity of the fatty acid sapienic acid (C(16:1Δ6)) against P. gingivalis and found that sapienic acid treatment alters both protein and lipid composition from those in controls. In this study, we further examined whole-cell protein differences between sapienic acid-treated bacteria and untreated controls, and we utilized open-source functional association and annotation programs to explore potential mechanisms for the antimicrobial activity of sapienic acid. Our analyses indicated that sapienic acid treatment induces a unique stress response in P. gingivalis resulting in differential expression of proteins involved in a variety of metabolic pathways. This network of differentially regulated proteins was enriched in protein-protein interactions (P = 2.98 × 10(-8)), including six KEGG pathways (P value ranges, 2.30 × 10(-5) to 0.05) and four Gene Ontology (GO) molecular functions (P value ranges, 0.02 to 0.04), with multiple suggestive enriched relationships in KEGG pathways and GO molecular functions. Upregulated metabolic pathways suggest increases in energy production, lipid metabolism, iron acquisition and processing, and respiration. Combined with a suggested preferential metabolism of serine, which is necessary for fatty acid biosynthesis, these data support our previous findings that the site of sapienic acid antimicrobial activity is likely at the bacterial membrane. IMPORTANCE: P. gingivalis is an important opportunistic pathogen implicated in periodontitis. Affecting nearly 50% of the population, periodontitis is treatable, but the resulting damage is irreversible and eventually progresses to tooth loss. There is a great need for natural products that can be used to treat and/or prevent the overgrowth of periodontal pathogens and increase oral health. Sapienic acid is endogenous to the oral cavity and is a potent antimicrobial agent, suggesting a potential therapeutic or prophylactic use for this fatty acid. This study examines the effects of sapienic acid treatment on P. gingivalis and highlights the membrane as the likely site of antimicrobial activity.

Indexed as

Amino AcidsBacterial ProteinsEnergy MetabolismGene Expression Regulation, BacterialOxygen ConsumptionPalmitic AcidsPorphyromonas gingivalisProtein Interaction MapsAmino AcidsBacterial Proteinsdelta(6)-hexadecenoic acidPalmitic Acids

Identifiers

PMID26483519
PMCPMC4686187
OpenAlexW2277020372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.